• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

126例非典型颅内脑膜瘤患者的无进展生存期及与术后复发相关的因素

Progression-Free Survival and Factors Associated with Postoperative Recurrence in 126 Patients with Atypical Intracranial Meningioma.

作者信息

Phonwijit Luckchai, Khawprapa Cheewin, Sitthinamsuwan Bunpot

机构信息

Division of Neurosurgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Division of Neurosurgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

出版信息

World Neurosurg. 2017 Nov;107:698-705. doi: 10.1016/j.wneu.2017.08.057. Epub 2017 Aug 31.

DOI:10.1016/j.wneu.2017.08.057
PMID:28838877
Abstract

OBJECTIVE

Atypical meningioma has a higher recurrence rate than benign meningioma. The mainstay of treatment is surgery with or without radiation therapy (RT). The objective of this study was to investigate progression-free survival (PFS) and factors associated with postoperative recurrence in patients with atypical meningioma.

METHODS

Patients with diagnoses of atypical menigioma who underwent surgery at Siriraj Hospital during the 2004 to 2014 study period were included. Features potentially associated with PFS and tumor recurrence from clinical records, operative records, and neuroimaging studies were evaluated and analyzed.

RESULTS

One hundred twenty-six patients (mean age, 55 years) were included. The median PFS was 55 months. The 5-year and 10-year PFS rates were 72.5% and 32%, respectively. The median follow-up duration was 52 months. In multivariate analysis, tumor location (convexity, parasagittal/falcine, intraventricular, skull base) (P = 0.003), and pial invasion (hazard ratio [HR]: 2.02; P = 0.045) were significantly associated with tumor recurrence. Postoperative RT was associated with reduction in tumor recurrence in both univariate (odds ratio: 0.48; P = 0.039) and multivariate analysis (HR: 0.42; P = 0.005).

CONCLUSIONS

Tumor location and pial invasion were significantly correlated with increased incidence of tumor recurrence, and postoperative RT was found to be significantly associated with decreased tumor progression and recurrence.

摘要

目的

非典型脑膜瘤的复发率高于良性脑膜瘤。治疗的主要方法是手术,可联合或不联合放射治疗(RT)。本研究的目的是调查非典型脑膜瘤患者的无进展生存期(PFS)以及与术后复发相关的因素。

方法

纳入2004年至2014年研究期间在诗里拉吉医院接受手术的非典型脑膜瘤患者。对临床记录、手术记录和神经影像学研究中可能与PFS和肿瘤复发相关的特征进行评估和分析。

结果

共纳入126例患者(平均年龄55岁)。PFS的中位数为55个月。5年和10年PFS率分别为72.5%和32%。中位随访时间为52个月。多因素分析显示,肿瘤位置(凸面、矢状窦旁/大脑镰、脑室内、颅底)(P = 0.003)和软脑膜侵犯(风险比[HR]:2.02;P = 0.045)与肿瘤复发显著相关。术后RT在单因素分析(优势比:0.48;P = 0.039)和多因素分析(HR:0.42;P = 0.005)中均与肿瘤复发减少相关。

结论

肿瘤位置和软脑膜侵犯与肿瘤复发发生率增加显著相关,且术后RT与肿瘤进展和复发减少显著相关。

相似文献

1
Progression-Free Survival and Factors Associated with Postoperative Recurrence in 126 Patients with Atypical Intracranial Meningioma.126例非典型颅内脑膜瘤患者的无进展生存期及与术后复发相关的因素
World Neurosurg. 2017 Nov;107:698-705. doi: 10.1016/j.wneu.2017.08.057. Epub 2017 Aug 31.
2
Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.颅底脑膜瘤患者的长期手术结果和生物学预后因素。
J Neurosurg. 2011 May;114(5):1278-87. doi: 10.3171/2010.11.JNS10701. Epub 2010 Dec 17.
3
Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.术后放疗对原发性颅内非典型脑膜瘤复发的影响。
J Neurooncol. 2020 Jan;146(2):347-355. doi: 10.1007/s11060-019-03382-x. Epub 2020 Jan 3.
4
Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute.基于点扫描的质子治疗颅内脑膜瘤:来自保罗谢尔研究所的长期结果。
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):865-71. doi: 10.1016/j.ijrobp.2011.08.027. Epub 2011 Dec 2.
5
Skull base atypical meningioma: long term surgical outcome and prognostic factors.颅底非典型脑膜瘤:长期手术结果及预后因素
Clin Neurol Neurosurg. 2015 Jan;128:112-6. doi: 10.1016/j.clineuro.2014.11.009. Epub 2014 Nov 24.
6
Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.世界卫生组织二级脑膜瘤全切术后辅助放疗的再探讨
World Neurosurg. 2017 Jul;103:655-663. doi: 10.1016/j.wneu.2017.04.095. Epub 2017 Apr 24.
7
Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.非典型脑膜瘤:161 例在我院接受手术与手术加放疗治疗患者的无进展生存期。
J Neurooncol. 2018 Jan;136(1):147-154. doi: 10.1007/s11060-017-2634-2. Epub 2017 Oct 28.
8
Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.非典型脑膜瘤的长期生存分析:生存率、预后因素、手术及放射治疗
Acta Neurochir (Wien). 2014 Aug;156(8):1475-81. doi: 10.1007/s00701-014-2156-z. Epub 2014 Jun 26.
9
Gamma Knife surgery for convexity, parasagittal, and falcine meningiomas.伽玛刀手术治疗凸面、矢状窦旁和镰旁脑膜瘤。
J Neurosurg. 2011 May;114(5):1392-8. doi: 10.3171/2010.11.JNS10112. Epub 2010 Dec 3.
10
Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.颅底脑膜瘤的粒子治疗后临床转归:主动扫描调强放疗的患者的毒性和局部控制
Radiat Oncol. 2018 Mar 27;13(1):54. doi: 10.1186/s13014-018-1002-5.

引用本文的文献

1
An evidence-based framework for postoperative surveillance of meningioma.脑膜瘤术后监测的循证框架。
Neurooncol Pract. 2024 Dec 2;12(3):478-488. doi: 10.1093/nop/npae117. eCollection 2025 Jun.
2
The dural attachment length predict prognosis in patients with recurrent meningiomas.硬脑膜附着长度可预测复发性脑膜瘤患者的预后。
Neurosurg Rev. 2024 Nov 11;47(1):843. doi: 10.1007/s10143-024-03076-7.
3
Impact on natural history of atypical meningioma after changes in 2016 edition of the world health organization (WHO) classification of central nervous system tumors: a literature review.
2016 年版世界卫生组织(WHO)中枢神经系统肿瘤分类改变后非典型脑膜瘤自然史的影响:文献复习。
Neurosurg Rev. 2024 Sep 28;47(1):704. doi: 10.1007/s10143-024-02881-4.
4
Multi-parameter MRI radiomic features may contribute to predict progression-free survival in patients with WHO grade II meningiomas.多参数磁共振成像的影像组学特征可能有助于预测世界卫生组织二级脑膜瘤患者的无进展生存期。
Front Oncol. 2024 Jun 28;14:1246730. doi: 10.3389/fonc.2024.1246730. eCollection 2024.
5
Predictor factors for recurrence in atypical meningiomas.非典型脑膜瘤复发的预测因素。
Rom J Morphol Embryol. 2023 Jul-Sep;64(3):333-342. doi: 10.47162/RJME.64.3.05.
6
A machine learning-based integrated clinical model for predicting prognosis in atypical meningioma patients.基于机器学习的综合临床模型,用于预测非典型脑膜瘤患者的预后。
Acta Neurochir (Wien). 2023 Dec;165(12):4191-4201. doi: 10.1007/s00701-023-05831-z. Epub 2023 Oct 11.
7
Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.放射治疗和立体定向放射外科作为非典型和间变性(世界卫生组织II级和III级)脑膜瘤辅助或挽救性治疗的疗效:一项系统评价和荟萃分析。
Neurosurg Rev. 2023 Mar 17;46(1):71. doi: 10.1007/s10143-023-01969-7.
8
NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas.NF2 突变与 2 级和 3 级复发性脑膜瘤的放射治疗抵抗有关。
J Neurooncol. 2023 Jan;161(2):309-316. doi: 10.1007/s11060-022-04197-z. Epub 2022 Nov 27.
9
Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients: A Meta-Analysis Study.非典型脑膜瘤患者的术后辅助放疗:一项荟萃分析研究
Front Oncol. 2021 Dec 2;11:787962. doi: 10.3389/fonc.2021.787962. eCollection 2021.
10
Establishment and Validation of an Integrated Model to Predict Postoperative Recurrence in Patients With Atypical Meningioma.建立和验证用于预测非典型脑膜瘤患者术后复发的综合模型。
Front Oncol. 2021 Oct 7;11:754937. doi: 10.3389/fonc.2021.754937. eCollection 2021.